Bryan Cave Leighton Paisner Adds Antitrust Litigation Partner

Law firm Bryan Cave Leighton Paisner (BCLP) announced that noted litigator Charles Tompkins has joined the firm as a partner in the Washington office. Charles joins from Williams Montgomery & John, where he was a member of the Executive Committee and chair of that firm’s Antitrust & Unfair Competition Practice.

Charles has more than 20 years’ experience in high-stakes litigation. He has represented clients across the US and internationally to recover damages caused by violations of antitrust and competition law. Clients include those involved in manufacturing, health care, retail and agriculture, including many Fortune 500 companies and national retailers.

Charles brings litigation and trial experience to BCLP to help clients efficiently resolve complex disputes in court and, when possible, prior to court action. He is well versed in navigating the complex client concerns that often spring from industry-wide allegations of anticompetitive activity.

A frequent speaker and author on antitrust matters, Charles has presented on the application of the Foreign Trade Antitrust Improvement Act (FTAIA) in modern global commercial transactions and on the intersection of antitrust liability and domestic and foreign bankruptcy law protections. He is the author of “Innovation Economics and the Law: The Health Care Industry’s Exposure to Antitrust Liability,” published by the American Bar Association Section of Antitrust Law, and “Damage Issues in Fair Labor Standards Act Collective Action Litigation,” published in the Employee Rights and Employment Policy Journal. He is noted in numerous industry rankings as a Leading Lawyer in both antitrust law and commercial litigation.

“We are excited to welcome Charles to BCLP and our Washington office, where his extensive litigation experience and antitrust prowess will build strength on strength, adding to BCLP’s top-shelf antitrust litigation team,” said Partner Rebecca Nelson, U.S. leader of BCLP’s Antitrust & Competition Practice.

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.